A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa

AIDS

Volumn 17, Issue 7, 2003, Pages 1045-1052

  Scotland, Graham S ^a,b   Van Teijlingen, Edwin R ^a   Van Der Pol, Marjon ^a   Smith, W Cairns S ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN MATERNITY HOSPITAL   (United Kingdom)

Author keywords

Africa; AIDS; Cost effectiveness; HIV; Mother to child transmission; Prevention

Indexed keywords

NEVIRAPINE; ZIDOVUDINE;

AFRICA; COST EFFECTIVENESS ANALYSIS; EMBASE; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SHORT COURSE THERAPY; SINGLE DRUG DOSE; VERTICAL TRANSMISSION;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; COUNSELING; DISEASE TRANSMISSION, VERTICAL; DRUG COSTS; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS;

EID: 0037541273     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200305020-00014     Document Type: Review

References (37)

1. UNAIDS. AIDS epidemic update, December 2001. http://www.unaids.org/epidemic_update/report_dec01/index.html
2. UNAIDS. Technical Update, mother-to-child transmission of HIV. September 2001. http://www.unaids.org/publications/documents/mtct/index.html
3. Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999, 353:786-792.
4. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999, 353:781-785.
5. DITRAME ANRS 049 Study Group. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. Lancet 1999, 354:2050-2051
6. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999, 353:773-780.
7. Gray G, for the PETRA Trial Management Committee. The Petra study: early and late efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1. XIII International Conference on AIDS. Durban, July 2000 [abstract LbOr5].
8. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354:795-802.
9. Deseyve M, Duefield C, Musisi M, Fleming T, Musoke P, Guay LA, et al. The one year safety and efficacy data of the HIVNET 012 trial. XIII International Conference on AIDS. Durban, July 2000 [abstract LbOr1].
10. McIntyre J, and the SAINT Study Team. Evaluation of the safety of two simple regimens for prevention of mother to child transmission (MTCT) of HIV infection: nevirapine (NVP) vs lamivudine (3TC) + zidovudine (ZDV) used in a randomized clinical trial (The SAINT study). XIII International Conference on AIDS. Durban, July 2000 [abstract TuOrg356].
11. UNAIDS. Report of the meeting on the evaluation of the UNAIDS HIV Drug Access Initiative. May 2000. http://www.unaids.org/publications/documents/care/index.html#unai ds
12. Walker D, Fox-Rushby JA. Economic evaluation of communicable disease interventions in developing countries: A critical review of the published literature. Health Econ 2000, 9:681-689.
13. Newell M.L, Dabis F, Tolley K, Whynes D. Cost-effectiveness and cost-benefit in the prevention of mother to child transmission of HIV in developing countries. AIDS 1998, 12:1571-1580.
14. Khan KS, Ter Riet G, Glanville J, Sowden AJ and Kleijnen J for the NHS Centre for Reviews and Dissemination. Undertaking Systematic Reviews of Research of Effectiveness - CRD's Guidance for Carrying Out or Commissioning Reviews. 2nd edn. CRD Report Number 4. York: NHS CRD University of York; 2000.
15. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996, 313:275-283.
16. Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA 1996, 276:139-145.
17. Mansergh G, Haddix AC, Steketee RW, Simonds RJ. Cost-effectiveness of zidovudine to prevent mother to child transmission of HIV in Sub-Saharan African. JAMA 1998, 280:30-31.
18. Marseille E, Kahn JG, Saba J. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS 1998, 12:939-948.
19. Wilkinson D, Floyd K, Gilks CF. Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. AIDS 1998, 12:1675-1682.
20. Soderlund N, Zwi K, Kinghorn, Gray G. Prevention of vertical transmission of HIV: analysis of cost effectiveness options available in South Africa. BMJ 1999, 318:1650-1655.
21. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Cost-effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 1999, 354:803-809.
22. Stringer JSA, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M. Stinnett AA. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr 2000, 24:369-377.
23. Wilkinson D, Floyd K, Gilks CF. National and provincial estimated costs and cost-effectiveness of a programme to reduce mother-to child HIV transmission in South Africa. S Afr Med J 2000, 90:794-798.
24. Wood E, Braitstein P, Montaner JSG, Schechter MT, Tyndall MW, O'Shaughnessy MV, et al. Extent to which low level antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet 2000, 355:2095-2100.
25. Krasovic K, Soderlund N. Cost effectiveness of feeding interventions for preventing mother-to-child transmission of HIV. XIII International Conference on AIDS. Durban, July 2000 [abstract WeOrC618].
26. World Bank. World Development Report 1993: Investing in Health. New York: Oxford University Press; 1993.
27. Population Council, Horizons. Prevention of mother-to-child transmission of HIV - Research update. January 2002. http://www.popcouncil.org/pdfs/horizons/rs/re_mtctc.pdf
28. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1 - A randomized clinical trial. JAMA 2000, 283:1167-1174.
29. Murray CJL, Acharya AK. Understanding DALYs. J Health Econ 1997, 16:703-730.
30. Cotton MF, Schaff HS, Van Veenendal M, Janse van Rensburg A, Janse van Rensburg E. The burden of mother to child transmission of HIV-1 disease in a low prevalence region - a five year study of hospitalised children. S Afr J Epidem Infect 1998, 13:46-49.
31. Busulwa WR, Buyse D, Mulligan J, Walker D, Fox-Rushby J. Analysing the analysis: a review of a set of economic evaluations of introduction of anti-retroviral therapy to reduce vertical HIV transmission in a hypothetical sub-Saharan African health district. http://www.iaen.org/papers/index.php
32. Kumaranayake L, Watts C. Economic costs of HIV/AIDS prevention activities in sub-Saharan Africa. AIDS 2000, 14(Suppl 3):S239-S252.
33. Söderlund N, Broomberg J, Lavis J, Mills A. The costs of HIV/AIDS prevention strategies in developing countries. Bull World Health Organ 1993, 71:595-604.
34. UNAIDS. Report on the global HIV/AIDS epidemic, June 2000. http://www.unaids.org/publications/documents/index.html
35. Taha TET, Miotti P, Liomba G, Dallabetta G, Chiphangwi J. HIV, maternal death and child survival in Africa. AIDS 1996, 10:111-112.
36. McDermott JM, Slutsker L, Steketee RW, Wirima JJ, Breman JG, Heymann DL. Prospective assessment of mortality among a cohort of pregnant women in rural Malawi. Am J Trop Med Hyg 1996, 55:66-70.
37. Bulterys M, Fowler MG, Shaffer N, Tih PM, Greenberg AE, Karita E, et al. Role of traditional birth attendants in preventing perinatal transmission of HIV. BMJ 2002, 324:222-225.